Molecular radiotherapy in prostate cancer
Molecular radiotherapy (MRT), also known as targeted radionuclide therapy or radioligand therapy, is emerging as a transformative approach in the treatment of prostate cancer, particularly in metastatic and castration-resistant cases. Unlike traditional external beam radiotherapy, MRT delivers targeted radiation internally using radioactive substances that bind to specific tumour markers, minimising damage to healthy tissue and […]

Dr Amy Eccles
Imperial College Healthcare NHS Trust

